Health Global News & Press Release Distribution

Health

All
APAC

Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024

HEFEI, China, June 10, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals today announced that a poster tour presentation highlighting the Phase 2a clinical data of KPG-818 in patients with Systemic Lupus Erythematosus (SLE) will be presented at the upcoming Annual European Congress of Rheumatology E...

2024-06-10 20:00 1771

FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A

* FDA's Fast Track designation speeds up the development of new biologic drugs for rare diseases YONGIN, South Korea, June 10, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA ...

2024-06-10 16:18 2068

J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- J INTS BIO provided an update of its ongoing Phase 1 clinical study of JIN-A02, a 4th generation EGFR-TKI for NSCLC treatment, during the 3rd of June poster session of the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held at Mc...

2024-06-10 13:56 1655

J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study

DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal denervation (RDN), today announced initiation of its Early Feasibility Study (EFS) for the HyperQure™ system following FDA IDE ap...

2024-06-10 13:14 1616

DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)

United Imaging Prepares to Ship its 30,000th Unit Globally, a uMI Panorama GS, from Houston for U.S. Installation

The uMI Panorama GS is among the all-digital Molecular Imaging systems United Imaging is featuring at SNMMI in Toronto SHANGHAI, June 8, 2024 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, is on the brink of a significant milestone as it a...

2024-06-08 21:00 4014

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers

BEIJING and PARIS, June 7, 2024 /PRNewswire/ -- Tsingke successfully wrapped up its debut at TIDES USA 2024, the premier event for oligonucleotides, peptides, mRNA, and genome editing. Held fromMay 14-17 at the Hynes Convention Center in Boston, the conference brought ...

2024-06-07 22:09 4206

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers

Amorepacific Hosts NBRI Symposium

Announces Results of Skin Aging Research Conducted in collaboration with The Johns Hopkins University School of Medicine SEOUL, South Korea, June 7, 2024 /PRNewswire/ -- Amorepacific hosted the "New Beauty Research Initiative (NBRI) Symposium" at its R&I Center in Yongin, Korea, onWednesday, Jun...

2024-06-07 21:00 3954

Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024

JINAN, China, June 6, 2024 /PRNewswire/ -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting convened fromMay 31 to June 4, 2024 in Chicago, USA, adopting a hybrid format. Among the presented works, three clinical studies from Qilu Pharmaceutical were selected for poster sessio...

2024-06-07 14:51 1579

Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024

Big Tree Cloud and Plutonian Announce Closing of Business Combination

Big Tree Cloud's shares and warrants are expected to begin trading on Nasdaq under the tickers "DSY" and "DSYWW", respectively, onJune 7, 2024 SHENZHEN, China, June 6, 2024 /PRNewswire/ -- Big Tree Cloud International Group Limited ("Big Tree Cloud" or the "Company"), a company devoted to the de...

2024-06-07 04:15 2136

Xiao-I Partners with Global Leader in Health Technology to Enhance Knowledge Management with AI Solutions

SHANGHAI, June 6, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading AI company, announces a contract is secured from a renowned multinational conglomerate in the health technology sector base inChina. This contract is set to revolutionize knowledge mana...

2024-06-06 20:01 4041

MicuRx: Successful Completion of Phase I Clinical Trial for Self-Developed MRX-8 Antibacterial Drug in China

* According to the World Health Organization (WHO), millions of patients face treatment difficulties or even life-threatening conditions due to resistant bacterial infections each year. * MRX-8 not only shows excellent safety and tolerability but also demonstrates strong antibacterial activit...

2024-06-06 19:52 1856

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

ROCKVILLE, Md., June 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced the appointment of...

2024-06-06 19:00 1456

MGI Tech Launches Whole Workflow Solution for Agricultural Large-Scale Low-pass Whole Genome Sequencing at PAG Asia 2024

SHENZHEN, China, June 6, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced a highly efficient whole workflow solution for agricultural large-scale Low-pass whole genome sequencing (Lo...

2024-06-06 17:00 2062

ECHO IQ TECHNOLOGY CHAMPIONED IN INDEPENDENT SCIENTIFIC REVIEW

Echo IQ's EchoSolv-AS decision-support software for cardiology delivers significant potential benefits to hospital networks according to independent scientific presentation at prestigious New York Valves scientific conference. NEW YORK, June 6, 2024 /PRNewswire/ -- At the Structural Heart Summit ...

2024-06-06 13:14 1710

Telehealth System Featuring Rokid Glass 2 Wins HHS Award

HANGZHOU, China, June 5, 2024 /PRNewswire/ -- Rokid's augmented reality (AR) devices are making significant inroads into the medical sector. Utilizing the industrial-grade, split monocular waveguide AR glasses Rokid Glass 2, Rokid's Partner Company has developed a remote diagnostic and therapeuti...

2024-06-06 11:36 1654

Telehealth System Featuring Rokid Glass 2 Wins HHS Award

Zepp Health's Amazfit Adds US Olympic Medalist Morgan Pearson and Italian National Endurance Icon Yemaneberhan Crippa to Team Amazfit Roster of Athlete Ambassadors

* Amazfit smartwatches and fitness wearables continue to unlock potential for endurance athletes with unparalleled performance benefits MILPITAS, Calif., June 5, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, ...

2024-06-06 06:04 1709

Regor to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

CAMBRIDGE, Mass., June 5, 2024 /PRNewswire/ -- Regor Therapeutics Group, a clinical-stage global biopharmaceutical company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Thursday, June 12. Dr.Xiayang Qiu, Founder and CEO, will rep...

2024-06-05 23:36 1405

Pricing plan from Done aims to make diagnosis and treatment of ADHD more accessible and affordable

SAN FRANCISCO, June 5, 2024 /PRNewswire/ -- Healthcare can be a significant financial burden on many individuals and families, even with insurance. The costs associated with one of the more common health issues in the US, the diagnosis and treatment of adult ADHD, can spill over into many aspects...

2024-06-05 22:00 1988

Pricing plan from Done aims to make diagnosis and treatment of ADHD more accessible and affordable

STRENGTHENING PATIENT CARE AND SAFETY IN COMPLEX, HIGH-RISK PAEDIATRIC LIVER TRANSPLANT SURGERY

Innovative mixed reality technology enhances pre-surgical planning at NUH's specialised paediatric organ transplant centre inSingapore SINGAPORE, June 5, 2024 /PRNewswire/ -- For the last three decades, the transplant team at theNational University Hospital (NUH)'s Department of Paediatric Surg...

2024-06-05 22:00 2027

STRENGTHENING PATIENT CARE AND SAFETY IN COMPLEX, HIGH-RISK PAEDIATRIC LIVER TRANSPLANT SURGERY

Oricell Presented Long-term Follow-up Data of OriCAR-017 in RRMM at 2024 ASCO Annual Meeting, Highlighting the Sustained Efficacy of GPRC5D CAR-T Therapy

SHANGHAI and ROSELAND, N.J., June 5, 2024 /PRNewswire/ -- Oricell Therapeutics, a pioneering clinical-stage biopharmaceutical company, has presented the two-year long-term follow-up results of OriCAR-017, an open-label Phase I study evaluating GPRC5D-targeted CAR-T therapy in patients with relaps...

2024-06-05 19:59 2038

1 ... 26 27 282930 31 32 ... 280